View All Questions

Reframe that helped our house: the crash isn't you being difficult, it's a predictable pharmacological event with a schedule. We literally put 'mum's meds fade' on the family calendar at 5:45. The kids stopped taking it personally, I stopped pretending it wasn't happening, dinner planning moved earlier. Logistics beat willpower.

Counterpoint to the poster above: mine really was underdosing. 40mg was a starter dose that happened to feel huge against 29 years of nothing. Kept a two-week log (focus 1-10, morning vs afternoon) before my follow-up and the afternoon numbers made the case for me. Log beats vibes, doctors respond to patterns.

Not necessarily. In adults, ADHD medication does not always need to be taken every single day, and recommendations should be guided by the following principles — namely, current functional needs, degree of impairment, and life context, rather than a blanket rule. Because stimulant ADHD medications work on the days they are taken and do not require weeks to build up in the system, some adults benefit from daily use, particularly when ADHD symptoms affect multiple areas of life such as work, relationships, emotional regulation, or self-care. In these cases, consistent daily dosing can provide stability and reduce day-to-day variability. For other adults, especially when impairment is more situational or phase-specific, it can be reasonable to use medication on workdays or during high-demand periods, with planned non-medicated days. This approach can reduce side effects, support autonomy, and align treatment with what the person actually needs at that stage of life. Clinically, the goal is not strict adherence for its own sake, but optimizing function and quality of life while minimizing risk. Any decision about daily versus intermittent use should be made collaboratively, monitored over time, and revisited as life circumstances change.

ADHD brains tend to “prefer” one stimulant family. You don’t know which until you try, but there are predictive patterns. Methylphenidate-based (MPH)Smoother onset More “cognitive clarity” Less emotional intensity Often better for inattentive presentations Lower risk of anxiety activation Shorter duration in many formulations Amphetamine-based (AMP)Stronger effect on motivation and drive More “get up and go” Often better for combined/hyperactive presentations Can be more activating (good or bad) Longer duration options Higher risk of appetite suppression and insomnia If anxiety is prominent then we would start with methylphenidate such as biphentin, concerta or foquest. If low motivation or initiation is the primary complaint then an amphetamine like vyvanse, or adderall XR would be initiated. If the primary presentation is inattentive then methylphenidate tends to be a better first trial. If the presentation is combined hyperactive and inattentive then amphetamine provides a stronger symptom control If there are issues with poor sleep and or poor appetite then methylphenidate would be preferred first choice. Response to past medications can also give a good clue as to what will work, for example if the patient or a first degree relative responds well to either a methylphenidate or amphetamine based medication. It is always important to remember this is a first trial, so starting low, titrate slow, assess function not feeling, tracking appetite, sleep and task performance is key.

Yes, what you’re describing is a common early reaction, especially with a first dose of a stimulant, and it’s understandable to feel unsure about what it means. Feeling calmer and more focused while also feeling slightly “off” or emotionally flat doesn’t automatically signal a problem, but it is information worth paying attention to. Clinically, the early phase of ADHD medication is often an adjustment period. When stimulation and mental noise reduce for the first time, some people experience the calm as unfamiliar rather than pleasant. The brain is operating differently, and that contrast alone can feel odd or distancing. A mild sense of flatness early on can also reflect the dose temporarily overshooting your optimal window, or simply your system acclimating to a new level of regulation. However, treatment response is evaluated over time and context, not based on a single day. Clinicians usually look at a few patterns to decide whether this is adjustment or a dose issue. If the “not myself” feeling fades over several days as focus and calm remain, it’s often considered a normal settling-in response. If emotional flattening persists, worsens, or starts to feel like reduced enjoyment, disconnection, or muted personality, that’s more suggestive of the dose being slightly too high or not the best fit. Another important factor is timing. Early side effects often soften within the first week, whereas true mismatches tend to stay consistent. Clinicians also pay attention to whether calm feels supportive or constricting, and whether you still feel emotionally present once the medication wears off. Many prescribers would suggest observing rather than reacting quickly. Noting how you feel across several days, including when the medication is active and when it isn’t, provides much more useful guidance than a single dose experience. Feeling calmer doesn’t mean you should feel unlike yourself, and the goal is a state that feels clearer and steadier, not emotionally dulled.

Track WHEN it slips, not just that it slips. My 'mid-afternoon fade' turned out to be a 5.5-hour mark you could set a clock by — that's not a bigger-dose conversation, that's a longer-formulation conversation. Completely different ask. The timing detail changed my prescription.

Yes, emotional flattening is a known and clinically recognized effect for some people on ADHD medication, especially stimulants. Stimulant medications work by increasing dopamine and norepinephrine in the brain to improve focus and regulation. For many people, this brings clarity and calm. For others, especially if the dose is slightly too high or not well matched, the increased regulation can dampen emotional range. Feelings may become quieter, muted, or less spontaneous. People often describe feeling focused but less emotionally connected or less like themselves. Clinicians pay close attention to this because emotional blunting is not the goal. ADHD treatment is meant to support functioning, not suppress personality or emotional life. Flattening can signal that the dose is higher than needed, the medication duration is too long, or that a different formulation might be a better fit. It is also important to distinguish flattening from relief. Some people are used to intense emotional swings, and when those calm down, it can initially feel like numbness. Over time, emotions often return in a more regulated form. If emotions feel absent, joy is reduced, or relationships feel affected, that is clinically significant. This is not something to push through silently. Adjustments often help. The right medication should help you function while still feeling emotionally present and recognizable to yourself.

Merci pour ça. Trois semaines de guanfacine, en plein dans la phase zombie, et j'étais à deux doigts d'arrêter. Savoir que ça lève vers la semaine trois me fait tenir. Le coup du « baisser le bruit de fond plutôt que monter le signal », c'est exactement la bonne description.

This is very common, and clinicians take it seriously because poor sleep can both mimic and worsen ADHD symptoms. The first step is teasing out timing and history. Clinicians look at whether attention, impulsivity, or executive function difficulties were present since childhood and across settings, or whether they appeared mainly after sleep problems started. ADHD is lifelong, while sleep related cognitive issues often fluctuate with sleep quality. A detailed sleep history is key. This includes sleep duration, consistency, insomnia, circadian delay, snoring or apnea symptoms, restless sleep, and daytime sleepiness. They also review caffeine use, screen time, shift work, and medication timing. Clinicians often assess both in parallel rather than choosing one. If sleep deprivation is severe, they may stabilize sleep first to see what symptoms persist. If ADHD traits remain despite adequate sleep, that supports a true ADHD diagnosis. Rating scales, collateral history, and functional impact help distinguish the two. In practice, many patients have both ADHD and a sleep disorder, and treatment usually targets both together. Improving sleep often improves focus, but it rarely explains everything when ADHD is present.

Devil's advocate because I think both things are true: I switched generic↔brand twice, felt differences both times, in both directions. At some point I had to admit my expectations were running the experiment. The manufacturer question is legit — but so is tracking a week of ratings before deciding the afternoon is actually shorter vs feels shorter.